Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics

NCT03511859 ·Status: UNKNOWN

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

NCT05054010 ·Status: ACTIVE_NOT_RECRUITING

Laser Spectroscopy of Breast Tissue Through a Needle Device

NCT00918788 ·Status: COMPLETED

Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI

NCT06663228 ·Status: RECRUITING

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

NCT03703557 ·Status: COMPLETED ·Phase: NA

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

NCT06979921 ·Status: ACTIVE_NOT_RECRUITING

Optical Detection of Malignancy During Percutaneous Interventions

NCT01730365 ·Status: COMPLETED

A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients

NCT05365204 ·Status: UNKNOWN ·Phase: PHASE1

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

NCT04480814 ·Status: COMPLETED

Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

NCT05800132 ·Status: RECRUITING ·Phase: NA

Automated Method for Breast Cancer Detection

NCT03863522 ·Status: TERMINATED ·Phase: NA

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

NCT07331506 ·Status: RECRUITING

Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

NCT02575612 ·Status: COMPLETED ·Phase: NA

MRD in High-risk EBC

NCT06566729 ·Status: ACTIVE_NOT_RECRUITING

A Multicenter Breast Cancer Biospecimen Registry

NCT02712645 ·Status: UNKNOWN

Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases

NCT06468124 ·Status: RECRUITING

A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

NCT02761616 ·Status: COMPLETED

Evaluation of the SmartBx System for Breast Biopsy

NCT03808116 ·Status: COMPLETED ·Phase: NA

Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology

NCT01368744 ·Status: COMPLETED

Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts

NCT04561297 ·Status: COMPLETED ·Phase: NA

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

NCT05955521 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Non Invasive Detection of Lung and Breast Cancer by Odor Signature

NCT02195076 ·Status: UNKNOWN

RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment

NCT02190227 ·Status: COMPLETED ·Phase: PHASE2

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

NCT01140776 ·Status: TERMINATED

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

NCT06672302 ·Status: RECRUITING